← Back to the full Peptide Guide overview
Important Disclaimer — Read Before Using This Page
This information is not intended for use by unlicensed individuals or by licensed professionals who lack adequate training and experience in assessing patients for peptide or hormone therapy. All clinical decisions and dosing must be made in consultation with a licensed, experienced physician and a licensed, experienced compounding pharmacist, and should be supported by published clinical studies.
The information presented here has been compiled using Artificial Intelligence, statements from videos and websites by apparent qualified professionals, and available published research. We strongly encourage exhaustive independent research before considering any therapy. Anyone starting a medication they have never taken before should take an extremely conservative approach.
Nothing on this page or in these videos should be taken as medical advice. These materials are provided only to help begin your research. All dosing and treatment decisions should be made between you and your medical providers after proper evaluation. We are not affiliated with any of the doctors whose videos appear on this page.
Selank International Compounded
Category: Cognitive & Neurological Support
How it works. Selank is a synthetic heptapeptide developed in Russia as a stabilized analog of tuftsin, an endogenous immunomodulator. It is registered in the Russian Federation as an anxiolytic and is described in the Russian clinical literature as reducing anxiety without the sedation, cognitive dulling, dependence, or withdrawal concerns that come with benzodiazepines. The principal published clinical literature is in Russian journals.
Why a physician might discuss it—and where the limits are. Selank is not FDA-approved and online intranasal products are overwhelmingly grey-market. A physician may discuss the concept in the context of mild-to-moderate anxiety, stress resilience, or fatigue-anxiety overlap—but it should not be used to avoid proper psychiatric evaluation or standard therapy when indicated. Severe panic disorder, bipolar disorder, suicidality, PTSD, OCD, pregnancy, breastfeeding, autoimmune disease, or complex psychiatric medication regimens are all reasons to decline and refer. Psychiatric patients can destabilize quickly, and casually experimenting with mood-active peptides in unstable patients is dangerous medicine.
What patients typically describe. Some patients report a calmer state without feeling drugged, sometimes within an hour of administration and sometimes building over several days. Improved sleep may follow, secondary to lower anxiety rather than direct sedation. Nasal irritation or headache can occur with the intranasal form. Any use should be paired with proper anxiety screening (PHQ-9, GAD-7), suicidality screening, current-psychiatric-medication review, and involvement of a PCP or psychiatrist.
Recommended Videos
Dr. Debra Durst, MD — Natural Anxiety Relief Without Benzodiazepines — What Is Selank?
Quinn Stillson, MD — Selank Deep Dive: Anxiety, Cognition, Immune System — Mechanisms, Risks, Forms, & Dosing
Dr. Adam Sewell, MD — Selank: Revolutionizing Mental Health and Cognitive Enhancement — A Doctor’s Guide
Video Sources & Independence
The videos linked on this page are provided solely for educational purposes. None of the physicians or channels featured are sponsored by, affiliated with, or compensated by NJ Weight Loss & Preventive Care Clinics, its physicians, or any individuals associated with our practice. We have selected these videos because they offer thoughtful, evidence-based discussion of mechanisms and clinical considerations. Viewers should evaluate all sources independently.
← Back to the full Peptide Guide overview · Peptide Dosing Reference →